Literature DB >> 11328840

Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.

R T Pirinen1, P Hirvikoski, R T Johansson, S Hollmén, V M Kosma.   

Abstract

AIMS: To investigate the expression of catenins (alpha, beta, and gamma) in non-small cell lung carcinoma (NSCLC) and its relation to clinicopathological factors and prognosis.
METHODS: The expression of catenins was analysed immunohistochemically in 261 patients with resected NSCLC, diagnosed between 1978 and 1996 in eastern Finland: The cell proliferation index of the tumours was analysed by means of an image analyser. The staining results were compared with clinicopathological characteristics and survival.
RESULTS: Normal catenin staining was found significantly more often in adenocarcinomas than in squamous cell carcinomas or anaplastic/large cell carcinomas. Reduced staining of alpha-catenin, beta-catenin, and gamma-catenin was related to poor differentiation of the tumour. The tumours with reduced staining of beta-catenin or gamma-catenin often had higher cell proliferation activity. Nuclear staining of beta-catenin and gamma-catenin was found in 16 (7%) and 29 (13%) cases, respectively. This nuclear staining correlated directly with increased cell proliferation and inversely with membranous staining. In survival analyses the predictors of overall and disease free survival were stage and tumour type. The expression of catenins did not affect survival.
CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value. However, this study supports the important role of the nuclear accumulation of beta-catenin and gamma-catenin in highly proliferative cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328840      PMCID: PMC1731412          DOI: 10.1136/jcp.54.5.391

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

1.  Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer.

Authors:  K Pantel; B Passlick; J Vogt; P Stosiek; M Angstwurm; R Seen-Hibler; K Häussinger; O Thetter; J R Izbicki; G Riethmüller
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

2.  Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer.

Authors:  M A Sulzer; M P Leers; J A van Noord; E C Bollen; P H Theunissen
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

3.  The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study.

Authors:  J M Retera; M P Leers; M A Sulzer; P H Theunissen
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

4.  Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.

Authors:  T Brabletz; A Jung; K Hermann; K Günther; W Hohenberger; T Kirchner
Journal:  Pathol Res Pract       Date:  1998       Impact factor: 3.250

5.  Level of alpha-catenin expression in colorectal cancer correlates with invasiveness, metastatic potential, and survival.

Authors:  I Raftopoulos; P Davaris; G Karatzas; P Karayannacos; G Kouraklis
Journal:  J Surg Oncol       Date:  1998-06       Impact factor: 3.454

6.  Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer.

Authors:  M Anttila; V M Kosma; H Ji; X Wei-Ling; J Puolakka; M Juhola; S Saarikoski; K Syrjänen
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

7.  Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity.

Authors:  C Bagutti; P M Speight; F M Watt
Journal:  J Pathol       Date:  1998-09       Impact factor: 7.996

8.  Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.

Authors:  K N Syrigos; K Harrington; J Waxman; T Krausz; M Pignatelli
Journal:  J Urol       Date:  1998-11       Impact factor: 7.450

9.  Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer.

Authors:  K Günther; T Brabletz; C Kraus; O Dworak; M A Reymond; A Jung; W Hohenberger; T Kirchner; F Köckerling; W G Ballhausen
Journal:  Dis Colon Rectum       Date:  1998-10       Impact factor: 4.585

10.  Cytoplasmic accumulation of alpha-catenin is associated with aggressive features in laryngeal squamous-cell carcinoma.

Authors:  P Hirvikoski; E J Kumpulainen; J A Virtaniemi; H J Helin; I Rantala; R T Johansson; M Juhola; V M Kosma
Journal:  Int J Cancer       Date:  1998-10-23       Impact factor: 7.396

View more
  31 in total

1.  A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.

Authors:  Giuseppe Pelosi; Aldo Scarpa; Giulia Veronesi; Lorenzo Spaggiari; Barbara Del Curto; Patrick S Moore; Patrick Maisonneuve; Angelica Sonzogni; Michele Masullo; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-09-13       Impact factor: 4.064

2.  Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer.

Authors:  T Leinonen; R Pirinen; J Böhm; R Johansson; A Rinne; E Weber; V-M Kosma
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

Review 3.  Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.

Authors:  C-Q Zhu; W Shih; C-H Ling; M-S Tsao
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

4.  Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile.

Authors:  Li Dong; Jun Deng; Ze-Min Sun; An-Ping Pan; Xiao-Jun Xiang; Ling Zhang; Feng Yu; Jun Chen; Zhe Sun; Miao Feng; Jian-Ping Xiong
Journal:  Tumour Biol       Date:  2015-04-10

5.  Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.

Authors:  Athamassios Kotsinas; Konstantinos Evangelou; Panayotis Zacharatos; Christos Kittas; Vassilis G Gorgoulis
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

6.  DLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activity.

Authors:  Veenu Tripathi; Nicholas C Popescu; Drazen B Zimonjic
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

7.  Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma.

Authors:  Juanjuan Che; Yifan Yang; Jing Xiao; Pengfei Zhao; Bo Yan; Shuo Dong; Bangwei Cao
Journal:  Tumour Biol       Date:  2015-03-28

8.  Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer.

Authors:  Yu-Jun Li; Xiang-Rui Ji
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Comparison of osteopontin, beta-catenin and hnRNP B1 expression in lung carcinomas.

Authors:  Muhammet Emin Guldur; Yasemin Kibar; Hale Deniz; Kemal Bakir
Journal:  Pathol Oncol Res       Date:  2009-07-17       Impact factor: 3.201

10.  Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.

Authors:  Astrid Rohrbeck; Jürgen Borlak
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.